Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/277
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms
Description: Subject matter which contains a six-membered heterocyclic ring consisting of one nitrogen and five carbon atoms.

Sub-classes under this class:

Class Number	Class Name	Patents
514/336	Additional hetero ring containing	849
514/354	C=o bonded directly to the six-membered hetero ring	436
514/345	Chalcogen bonded directly to ring carbon of the six-membered hetero ring	721
514/344	Cyano bonded directly to the six-membered hetero ring	249
514/352	Nitrogen attached directly to the six-membered hetero ring by nonionic bonding	778
514/357	Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding	1,297
514/315	Piperidines	783
514/332	Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms	544
514/279	Polycyclo ring system having the six-membered hetero ring as one of the cyclos	278
514/278	Spiro ring system	797
514/358	The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)	152

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Patent Number	Title Of Patent	Date Issued
7618988	Use of substituted aminomethyl chromans	Nov. 17, 2009
7618966	Abnormal Cannabidiols as agents for lowering intraocular pressure	Nov. 17, 2009
7612101	Abnormal cannabidiols as agents for lowering intraocular pressure	Nov. 3, 2009
7585874	Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives	Sep. 8, 2009
7572461	Borer-resistant wood, wood products, and wooden structures and methods	Aug. 11, 2009
7572816	Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders	Aug. 11, 2009
7563774	Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes	Jul. 21, 2009
7550476	Condensed polycyclic compounds	Jun. 23, 2009
7550475	Condensed polycyclic compounds	Jun. 23, 2009
7550474	Substituted phenyl acetamides and their use as protease inhibitors	Jun. 23, 2009
7550461	Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases	Jun. 23, 2009
7531529	Imidazole derivatives	May. 12, 2009
7514453	Method for enhancing mutant protein activity	Apr. 7, 2009
7514094	Pesticidal composition	Apr. 7, 2009
7510726	Methods and compositions for deterring abuse of opioid containing dosage forms	Mar. 31, 2009
7511034	Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses	Mar. 31, 2009
7498337	Acid secretion inhibitor	Mar. 3, 2009
7495001	Benzannelated derivatives, their manufacture and use as pharmaceutical agents	Feb. 24, 2009
7482357	17-acetamido-4-azasteroid derivatives as androgen receptor modulators	Jan. 27, 2009
7482358	Imidazoline compounds	Jan. 27, 2009
7476402	Methods and compositions for deterring abuse of opioid containing dosage forms	Jan. 13, 2009
7470702	Benzimidazoles	Dec. 30, 2008
7459461	Phosphonic acid compounds as inhibitors of serine proteases	Dec. 2, 2008
7446098	Combination therapy for treating protein deficiencies	Nov. 4, 2008
7435729	Compounds and methods for modulation of estrogen receptors	Oct. 14, 2008
7423012	Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors	Sep. 9, 2008
7414056	Pyrazole-amide compounds useful as kinase inhibitors	Aug. 19, 2008
7407939	Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics	Aug. 5, 2008
7399769	Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives	Jul. 15, 2008
7396840	Chemokine receptor binding heterocyclic compounds	Jul. 8, 2008
7393856	Anti-viral uses of borinic acid complexes	Jul. 1, 2008
7390810	Pyrazole-amine compounds useful as kinase inhibitors	Jun. 24, 2008
7381731	Pharmaceutical composition comprising citrulline	Jun. 3, 2008
7378412	Pharmaceutical compounds	May. 27, 2008
7378425	(1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds	May. 27, 2008
7371747	Cyanoalkylamino derivatives as protease inhibitors	May. 13, 2008
7354895	Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors	Apr. 8, 2008
7338961	Sphingosine kinase inhibitors	Mar. 4, 2008
7338960	Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activators	Mar. 4, 2008
7335664	Colon cleansing composition and method	Feb. 26, 2008
7332500	Heterocyclic antiviral compounds	Feb. 19, 2008
7326723	Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same	Feb. 5, 2008
7320982	Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-.beta. 1	Jan. 22, 2008
7320983	.alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors	Jan. 22, 2008
7297702	Contraception method using competitive progesterone antagonists and novel compounds useful therein	Nov. 20, 2007
7291625	Use of a vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation	Nov. 6, 2007
RE39916	Compounds that modulate PPAR activity and methods for their preparation	Nov. 6, 2007
7276514	Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof	Oct. 2, 2007
7273872	Inhibition of inflammation using .alpha. 7 receptor-binding cholinergic agonists	Sep. 25, 2007
7265107	Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes	Sep. 4, 2007